Form D · Biotechnology

Notable Labs, Inc.

Foster City, CA · CIK 0001674834

Offering snapshot reported Mar 8, 2023 · SEC filing

Reported sold
$10.3M
Offering amount: $10.3M
Investors reported
26
Form D · investor count
Minimum accepted
$0
Reported outside-investor minimum
First sale
Feb 21, 2023
As reported in this filing

What changed?

Latest filing versus its linked predecessor, where available.

No comparable changes in the displayed metrics.

Filing history

Scroll to see all columns →

FiledFiling typeReported soldChange vs linked filingInvestorsSource
Mar 8, 2023Initial$10,336,259No comparison26SEC filing
Jul 15, 2022Initial$10,063,252No comparison19SEC filing
Dec 13, 2019Initial$39,757,561No comparison37SEC filing
Aug 31, 2017Initial$14,840,492No comparison95SEC filing
Mar 16, 2017Initial$2,715,000No comparison23SEC filing
May 17, 2016Initial$4,488,500No comparison40SEC filing

Offering details

Securities
Equity, Option to acquire
Exemptions
06b
Duration over one year
No
Business combination
Yes
Sales commissions
$310K
Finders' fees
$0
Form D file number
021-475258

Sales compensation recipients

Scroll to see all columns →

RecipientCRDAssociated broker-dealer
JMP Securities LLC22208

Source: Form D, filed Mar 8, 2023. Minimum accepted may differ from a standard advertised minimum.

Fund connections

No confirmed ADV fund connection is available for this issuer.

People & organizations

Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.

People and organizations reported in Form D filings
NameReported role
Thomas Bock Director, Executive
Matthew De Silva Director
Amanda Hermann Executive
Michael Horowitz Executive
James Kim Director
Pete Quinzio Director, Executive, Promoter
Peter Quinzio Director, Executive
Adam Seabrook Director
Joseph Wagner Executive

Issuer details

Industry: Biotechnology (See others in industry)

Address:
320 Hatch Drive
Foster City, CA, 94404